Canadian Manufacturer Draws Warning for Sterility Issues

Drug Industry Daily
A A
The FDA hit Montreal-based drugmaker Lernapharm (Loris) with a warning letter over serious sterility violations and air filtration problems that were not resolved after a December 2017 inspection.

To View This Article:

Login

Subscribe To Drug Industry Daily